Sridhar J, Goyal N, Liu J, Foroozesh M. Review of ligand specificity factors for CYP1A subfamily enzymes from molecular modeling studies reported to-date. Molecules (Basel, Switzerland). 2017;22(7). https://doi.org/10.3390/molecules22071143.

Shimada T, Yun CH, Yamazaki H, Gautier JC, Beaune PH, Guengerich FP. Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol Pharmacol. 1992;41(5):856–64.

CAS  PubMed  Google Scholar 

Klomp F, Wenzel C, Drozdzik M, Oswald S. Drug-drug interactions involving intestinal and hepatic CYP1A enzymes. Pharmaceutics. 2020;12(12):1201. https://doi.org/10.3390/pharmaceutics12121201.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yengi LG, Xiang Q, Pan J, Scatina J, Kao J, Ball SE, et al. Quantitation of cytochrome P450 mRNA levels in human skin. Anal Biochem. 2003;316(1):103–10. https://doi.org/10.1016/s0003-2697(03)00042-3.

Article  CAS  PubMed  Google Scholar 

van de Kerkhof EG, Graaf IAMd, Ungell A-LB, Groothuis GMM. Induction of metabolism and transport in human intestine: validation of precision-cut slices as a tool to study induction of drug metabolism in human intestine in vitro. Drug Metab Dispos. 2008;36(3):604–13. https://doi.org/10.1124/dmd.107.018820.

Article  CAS  PubMed  Google Scholar 

Nishimura M, Yaguti H, Yoshitsugu H, Naito S, Satoh T. Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi. 2003;123(5):369–75. https://doi.org/10.1248/yakushi.123.369.

Article  CAS  PubMed  Google Scholar 

Hakkola J, Raunio H, Purkunen R, Pelkonen O, Saarikoski S, Cresteil T, et al. Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem Pharmacol. 1996;52(2):379–83. https://doi.org/10.1016/0006-2952(96)00216-x.

Article  CAS  PubMed  Google Scholar 

Walsh AA, Szklarz GD, Scott EE. Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism. J Biol Chem. 2013;288(18):12932–43. https://doi.org/10.1074/jbc.M113.452953.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther. 1994;270(1):414–23.

CAS  PubMed  Google Scholar 

Smith CAD, Smith G, Wolf CR. Genetic polymorphisms in xenobiotic metabolism. Eur J Cancer. 1994;30(13):1921–35. https://doi.org/10.1016/0959-8049(94)00382-F.

Article  Google Scholar 

Stiborová M, Martínek V, Rýdlová H, Koblas T, Hodek P. Expression of cytochrome P450 1A1 and its contribution to oxidation of a potential human carcinogen 1-phenylazo-2-naphthol (Sudan I) in human livers. Cancer Lett. 2005;220(2):145–54. https://doi.org/10.1016/j.canlet.2004.07.036.

Article  CAS  PubMed  Google Scholar 

Wegler C, Wiśniewski JR, Robertsen I, Christensen H, KristofferHertel J, Hjelmesaeth J, et al. Drug disposition protein quantification in matched human jejunum and liver from donors with obesity. Clin Pharmacol Ther. 2022;111(5):1142–54. https://doi.org/10.1002/cpt.2558.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wahid M, Mahjabeen I, Baig RM, Kayani MA. Expression of CYP1A1 and GSTP1 in human brain tumor tissues in Pakistan. Asian Pac J Cancer Prev: APJCP. 2013;14(12):7187–91. https://doi.org/10.7314/apjcp.2013.14.12.7187.

Article  PubMed  Google Scholar 

Paine MF, Hart HL, Ludington SS, Haining RL, Rettie AE, Zeldin DC. The human intestinal cytochrome P450 “pie.” Drug Metab Dispos. 2006;34(5):880–6. https://doi.org/10.1124/dmd.105.008672.

Article  CAS  PubMed  Google Scholar 

Ma X, Idle JR, Krausz KW, Gonzalez FJ. Metabolism of melatonin by human cytochromes p450. Drug Metab Dispos. 2005;33(4):489–94. https://doi.org/10.1124/dmd.104.002410.

Article  CAS  PubMed  Google Scholar 

Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology. 2003;144(8):3382–98. https://doi.org/10.1210/en.2003-0192.

Article  CAS  PubMed  Google Scholar 

Becker C, Frey R, Unger S, Thomas D, Reber M, Weimann G, et al. Pharmacokinetic interaction of riociguat with ketoconazole, clarithromycin, and midazolam. Pulm Circ. 2016;6(Suppl 1):S49-57. https://doi.org/10.1086/685016.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lang D, Radtke M, Bairlein M. Highly Variable expression of CYP1A1 in human liver and impact on pharmacokinetics of riociguat and granisetron in humans. Chem Res Toxicol. 2019;32(6):1115–22. https://doi.org/10.1021/acs.chemrestox.8b00413.

Article  CAS  PubMed  Google Scholar 

Werlinder V, Backlund M, Zhukov A, Ingelman-Sundberg M. Transcriptional and post-translational regulation of CYP1A1 by primaquine. J Pharmacol Exp Ther. 2001;297(1):206–14.

CAS  PubMed  Google Scholar 

Santes-Palacios R, Ornelas-Ayala D, Cabanas N, Marroquin-Perez A, Hernandez-Magana A, Olguin-Reyes SdR, et al. Regulation of human cytochrome P4501A1 (hCYP1A1): a plausible target for chemoprevention? BioMed Res Int. 2016;5341081/1. https://doi.org/10.1155/2016/5341081.

Lekas P, Tin KL, Lee C, Prokipcak RD. The human cytochrome P450 1A1 mRNA is rapidly degraded in HepG2 cells. Arch Biochem Biophys. 2000;384(2):311–8. https://doi.org/10.1006/abbi.2000.2115.

Article  CAS  PubMed  Google Scholar 

Zhao X, Wang Z, Wang Y, Zhang H, Blode H, Yoshikawa K, et al. Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in healthy young Chinese male non-smokers and smokers: results of a randomized, double-blind, placebo-controlled study. Clin Pharmacokinet. 2016;55(5):615–24. https://doi.org/10.1007/s40262-015-0337-4.

Article  CAS  PubMed  Google Scholar 

Dong D, Wu B, Chow D, Hu M. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling. Drug Metab Rev. 2012;44(2):192–208. https://doi.org/10.3109/03602532.2011.645580.

Article  CAS  PubMed  Google Scholar 

Bart AG, Takahashi RH, Wang X, Scott EE. Human cytochrome P450 1A1 adapts active site for atypical nonplanar substrate. Drug Metab Dispos. 2020;48(2):86–92. https://doi.org/10.1124/dmd.119.089607.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saravanakumar A, Sadighi A, Ryu R, Akhlaghi F. Physicochemical properties, biotransformation, and transport pathways of established and newly approved medications: a systematic review of the top 200 most prescribed drugs vs. the FDA-approved drugs between 2005 and 2016. Clin Pharmacokinet. 2019;58(10):1281–94. https://doi.org/10.1007/s40262-019-00750-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lang D, Jungmann N. Drug library screening for human CYP1A1 substrates. Drug Metab Pharmacokinet. 2020;35(1, Supplement):S28. https://doi.org/10.1016/j.dmpk.2020.04.022.

Article  Google Scholar 

Takahashi RH, Wang X, Segraves NL, Wang J, Chang JH, Khojasteh SC, et al. CYP1A1-mediated intramolecular rearrangement of aminoazepane in GDC-0339. Drug Metab Dispos. 2017;45(10):1084–92. https://doi.org/10.1124/dmd.117.076786.

Article  CAS  PubMed  Google Scholar 

Tess D, Chang GC, Keefer C, Carlo A, Jones R, Di L. In vitro-in vivo extrapolation and scaling factors for clearance of human and preclinical species with liver microsomes and hepatocytes. AAPS J. 2023;25(3):40. https://doi.org/10.1208/s12248-023-00800-x.

Article  CAS  PubMed  Google Scholar 

Certara Drug Interaction Solution https://www.druginteractionsolutions.org/

Andersen LP, Werner MU, Rosenkilde MM, Harpsøe NG, Fuglsang H, Rosenberg J, et al. Pharmacokinetics of oral and intravenous melatonin in healthy volunteers. BMC Pharmacol Toxicol. 2016;17:8. https://doi.org/10.1186/s40360-016-0052-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Price E, Kalvass JC, DeGoey D, Hosmane B, Doktor S, Desino K. Global analysis of models for predicting human absorption: QSAR, in vitro, and preclinical models. J Med Chem. 2021;64(13):9389–403. https://doi.org/10.1021/acs.jmedchem.1c00669.

Article  CAS  PubMed  Google Scholar 

Mebendazole HB. In: Enna SJ, Bylund DB, editors. xPharm: the comprehensive pharmacology reference. New York: Elsevier; 2007. p. 1–5.

Google Scholar 

Rosenkranz B, Winkelmann BR, Parnham MJ. Clinical pharmacokinetics of molsidomine. Clin Pharmacokinet. 1996;30(5):372–84. https://doi.org/10.2165/00003088-199630050-00004.

Article  CAS  PubMed  Google Scholar 

Keefer C, Chang G, Carlo A, Novak JJ, Banker M, Carey J, et al. Mechanistic insights on clearance and inhibition discordance between liver microsomes and hepatocytes when clearance in liver microsomes is higher than in hepatocytes. Eur J Pharm Sci. 2020;155: 105541. https://doi.org/10.1016/j.ejps.2020.105541.

Article  CAS  PubMed  Google Scholar 

Xu B, Ding J, Chen KX, Miao ZH, Huang H, Liu H, et al. Advances in cancer chemotherapeutic drug research in China. Recent Adv Cancer Res Ther. 2012;287-350. https://doi.org/10.1016/b978-0-12-397833-2.00012-1.

Davies M, Peramuhendige P, King L, Golding M, Kotian A, Penney M, et al. Evaluation of in vitro models for assessment of human intestinal metabolism in drug discovery. Drug Metab Dispos. 2020;DMD-AR-2020-000111. https://doi.org/10.1124/dmd.120.000111.

Zhang Z, Li Y, Stearns RA, Ortiz De Montellano PR, Baillie TA, Tang W. Cytochrome P450 3A4-mediated oxidative conversion of a cyano to an amide group in the metabolism of pinacidil. Biochemistry. 2002;41(8):2712–8. https://doi.org/10.1021/bi0119971.